17beta‐HSD1 has focused on this investigation as a target receptor for the development of anti‐BC drug discovery since this enzyme (17beta‐HSD1) leads the biosynthesis and metabolism of oestrogen plays a significant role to the proliferation and progression of the BC. This evidence concerns the gene HSD17B1 and breast cancer.